U.K. Approves Oxford-AstraZeneca vaccine as Cases Surge; Germany, South Korea Report Record Deaths

HeadlineDec 30, 2020

In international news, Britain has granted emergency authorization for the Oxford and AstraZeneca vaccine. The vaccine costs significantly less than the Moderna and Pfizer-BioNTech ones and does not require storage in ultra-cold freezers. Some trials showed it had a lower efficacy rate. The U.K. registered a record 53,000 new cases Tuesday.

Meanwhile, China’s Sinopharm says its coronavirus vaccine is 79% effective, and is seeking approval from regulators, although some 1 million or more people reportedly already received a Sinopharm vaccine as part of an emergency use program.

Germany reported its highest daily death toll at over 1,100 deaths. South Korea also reported its own new record of 40 deaths.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation
Top